Bio-Rad Laboratories (BIO) Total Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO) has 18 years of Total Liabilities data on file, last reported at $2.9 billion in Q1 2026.

• Total Liabilities for Q1 2026 came in at $2.9 billion, up 3.2% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.9 billion (up 3.2% YoY), and the FY2025 annual result was $3.1 billion, up 11.74% from the prior year.
• Total Liabilities slipped to $2.9 billion in Q1 2026 per BIO's latest filing, from $3.1 billion in the prior quarter.
• Over five years, Total Liabilities peaked at $4.2 billion in Q1 2022 and troughed at $2.8 billion in Q4 2024.
• A 5-year average of $3.4 billion and a median of $3.5 billion in 2023 frame the typical range for Total Liabilities.
• On a YoY basis, Total Liabilities climbed as much as 26.07% in 2022 and fell as far as 21.99% in 2022.
• A 5-year view of Total Liabilities shows it stood at $3.9 billion in 2022, then retreated by 8.45% to $3.6 billion in 2023, then retreated by 21.45% to $2.8 billion in 2024, then advanced by 11.74% to $3.1 billion in 2025, then slipped by 5.9% to $2.9 billion in 2026.
• Business Quant data shows BIO's Total Liabilities at $2.9 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.0 billion in Q3 2025.